GLSI
Greenwich LifeSciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
GLSI vs peer average
25/100
GLSI vs. peer average (F vs. C)
Grade spread
A 1 · B 2 · C 3 · D 1 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
KROS is the first available peer comparator.
Same-sector, similar-market-cap comparator; relevant mainly as a broad biotech reference rather than a direct clinical or commercial comp.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GLSI
Greenwich LifeSciences
KROS
Keros Therapeutics
Grade
F
A
Momentum
27
73
Value
41
61
Sentiment
36
65
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs KROS
GLSI / KROS
Grade Position
Below peers
GLSI vs. peer average (F vs. C)
25/100
Momentum
27
KROSValue
41
KROSSentiment
36
KROSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GLSI
KROS is the first peer returned for this comparison set.